8-K filing — Airsculpt Technologies, Inc. (AIRS)
Filed: 2026-08-12 AccNo: 0001870940-26-000041 Size: 147 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Replimune Group (NASDAQ:REPL) shares increased by 134.6% to $12.69 during Friday's pre-market session. Moleculin Biotech (NASDAQ:MBRX) shares increased by 17.64% to $1.2. The market value of their
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 31, 2026, 12:05 PM
- Checked
- Jul 31, 2026, 12:05 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Crude Oil Surges 3%; Sionna Therapeutics Shares Plunge
US stocks mixed, Dow Jones down 0.2% midday. Energy shares up 3%, real estate down 1.4%. National Energy Services up 16% on strong earnings.
Read original at benzingaUS Stocks Edge Lower; Monday.Com Shares Tumble After Q2 Results
Dow Jones fell 0.2% as US stocks opened lower. Energy shares rose 1.9%, while real estate stocks dropped 0.9%. Monday.com shares fell 10%.
Read original at benzingaAirSculpt Technologies shares are trading lower after the company reported worse-than-expected Q2 sales results and narrowed its FY26 sals guidance below estimates.
Read original at benzingaBTIG Reiterates Buy on Bioage Labs, Maintains $40 Price Target
BTIG analyst Thomas Shrader reiterates Bioage Labs (NASDAQ:BIOA) with a Buy and maintains $40 price target.
Read original at benzingaBioage Labs Q2 EPS $(0.58) Beats $(0.60) Estimate, Sales $2.451M Beat $1.920M Estimate
Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.60) by 3.33 percent. This is a 3.33 percent increase over losses of $(0.60) per share from the
Read original at benzinga